Time to Confirmed Neuroinfectious Diagnoses: Diagnostic Testing and Resource Allocation
- PMID: 38895000
- PMCID: PMC11181986
- DOI: 10.1177/19418744241242957
Time to Confirmed Neuroinfectious Diagnoses: Diagnostic Testing and Resource Allocation
Abstract
Background and objectives: In a retrospective study evaluating the diagnostic approach of definitive neurological infections at a tertiary referral center, we assessed the time to diagnosis from presentation, number of diagnostic tests ordered, and modality of etiologic diagnosis.
Methods: A total of 111 confirmed clinical cases of neurological infections from 2010-2018 were reviewed. Definitive neuroinfectious diagnoses were defined by positive cerebrospinal (CSF) polymerase chain reaction (PCR)/antigen, CSF culture, CSF antibody, serology, or pathology tests.
Results: An etiologic diagnosis was determined at an average (SD) of 3.1 (5.9) days after presentation with an average (SD) of 27.7 (15.6) diagnostic tests ordered per workup.Viral neuro-infections were associated with lower intensive care unit (ICU) admission rates, shorter length of hospitalization, and fewer diagnostic tests ordered, as well as shorter time to definitive diagnosis (P < .05). Longer hospitalizations were associated with immunosuppression status regardless of infectious etiology (P < .001).
Discussion: Given the high morbidity and mortality of neuroinfectious disease, specifically meningitis and encephalitis, efficient diagnostic testing is imperative to facilitate the most appropriate clinical course of action with special attention to the specific patient population.
Keywords: central nervous system infections; diagnosis; neuroinfectious disease.
© The Author(s) 2024.
Conflict of interest statement
The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
Similar articles
-
Diagnostic Accuracy of Cerebrospinal Fluid Multiplex Polymerase Chain Reaction Panel Testing in Patients With Suspected Central Nervous System Infections: A Multi-Center Study in the United Arab Emirates.Cureus. 2024 Jan 8;16(1):e51906. doi: 10.7759/cureus.51906. eCollection 2024 Jan. Cureus. 2024. PMID: 38333447 Free PMC article.
-
Prevalence and Characteristics of Neuroinfectious Disease Inquiries Within the Emerging Infections Network: A 22-Year Retrospective Study.Open Forum Infect Dis. 2020 May 9;7(6):ofaa163. doi: 10.1093/ofid/ofaa163. eCollection 2020 Jun. Open Forum Infect Dis. 2020. PMID: 32550236 Free PMC article.
-
Detection of human herpesviruses in cerebrospinal fluids collected from patients suspected of neuroinfectious diseases.J Neurovirol. 2022 Feb;28(1):92-98. doi: 10.1007/s13365-021-01040-5. Epub 2021 Dec 30. J Neurovirol. 2022. PMID: 34970721
-
Diagnostic Testing of Neurologic Infections.Neurol Clin. 2018 Nov;36(4):687-703. doi: 10.1016/j.ncl.2018.07.004. Neurol Clin. 2018. PMID: 30366549 Free PMC article. Review.
-
Herpes simplex virus infections of the central nervous system: encephalitis and meningitis, including Mollaret's.Herpes. 2004 Jun;11 Suppl 2:57A-64A. Herpes. 2004. PMID: 15319091 Review.
Cited by
-
Seven-year performance of a clinical metagenomic next-generation sequencing test for diagnosis of central nervous system infections.Nat Med. 2024 Dec;30(12):3522-3533. doi: 10.1038/s41591-024-03275-1. Epub 2024 Nov 12. Nat Med. 2024. PMID: 39533109 Free PMC article.
References
-
- Mount HR, Boyle SD. Aseptic and bacterial meningitis: evaluation, treatment, and prevention. Am Fam Physician. 2017;96:314-322. - PubMed
LinkOut - more resources
Full Text Sources